BHC Bausch Health Companies Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BHC Stock | Fundamental Analysis & Investment Insights
NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
Current Price
Live
$5.91
Analyst Target
$7.43
+25.7%
Upside
52W High
$8.69
52W Low
$4.25
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
78%
Analysis Accuracy
The deterministic health scores paint a concerning picture, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no Altman Z-Score available to confirm solvency, raising red flags. Despite a low P/E of 6.79 and forward P/E of 1.41 suggesting potential undervaluation, the negative Price/Book ratio (-3.88) implies serious equity deficiencies or accumulated losses. Strong operating and gross margins contrast sharply with a sky-high Debt/Equity ratio of 59.11, indicating extreme leverage risk. Insider selling, weak technical trend (0/100), and a 5-year price decline of 78.1% further underscore investor skepticism and structural challenges.
Key Strengths
High gross margin (70.67%) indicating strong pricing power or cost control in core operations
Solid operating margin (26.74%) relative to sector average
Revenue growth of 6.80% YoY in a competitive specialty pharma environment
Recent earnings surprises have been strongly positive, including a +788.9% beat in Q3 2025
Low forward P/E of 1.41 suggests market expects significant earnings acceleration
Key Risks
Extremely high Debt/Equity ratio of 59.11, far above sector average of 2.26, indicating severe financial leverage and refinancing risk
Piotroski F-Score of 4/9 signals weak financial health, particularly concerning given lack of Altman Z-Score for validation
Negative Price/Book ratio (-3.88) suggests book value is negative, a sign of accumulated losses or negative equity
Insider selling activity in last 6 months (2 sell transactions, $0.22M value) signals lack of confidence from insiders
Technical trend score of 0/100 indicates strong bearish momentum across price indicators
AI Fair Value Estimate
Based on comprehensive analysis
$6.09
+3.0% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BHC against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BHC from our newsroom.
Newest → oldest
No matching news yet.